APA (7th ed.) Citation

M, F., JD, W., AD, S., H, D., X, L., X, G., . . . JS, R. (2026). Drug and country characteristics associated with global approval and launch of FDA-approved novel therapeutics. Health affairs scholar, 4(7), qxag181. https://doi.org/10.1093/haschl/qxag181

Chicago Style (17th ed.) Citation

M, Fu, Wallach JD, So AD, Doernberg H, Li X, Guan X, Ramachandran R, and Ross JS. "Drug and Country Characteristics Associated with Global Approval and Launch of FDA-approved Novel Therapeutics." Health Affairs Scholar 4, no. 7 (2026): qxag181. https://doi.org/10.1093/haschl/qxag181.

MLA (9th ed.) Citation

M, Fu, et al. "Drug and Country Characteristics Associated with Global Approval and Launch of FDA-approved Novel Therapeutics." Health Affairs Scholar, vol. 4, no. 7, 2026, p. qxag181, https://doi.org/10.1093/haschl/qxag181.